Login / Signup

Comparative effectiveness of mycophenolate mofetil versus cyclophosphamide in systemic sclerosis-related interstitial lung disease.

Konstantinos GkiourasMaria G GrammatikopoulouTheodora SimopoulouZoe DaniilDimitrios Petros Bogdanos
Published in: Clinical rheumatology (2021)
Keyphrases
  • systemic sclerosis
  • interstitial lung disease
  • low dose
  • high dose
  • rheumatoid arthritis
  • drug induced